CHASITY PARSONS: Open Payments
NPI 1518422948 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 41 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $278 |
| SK Life Science, Inc. | 7 | $180 |
| Lundbeck LLC | 5 | $96 |
| Lilly USA, LLC | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: UBRELVY, QULIPTA, AMYVID, REXULTI, VYEPTI, NURTEC ODT, Symbravo, WAINUA.
Industry payments across TX — which companies pay providers there.
